Institute of Tropical Medicine Antwerp
Foundation of Public Utility

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study) [letter - Epub ahead of print]

DSpace/Manakin Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)